Newsletter | February 4, 2026

02.04.26 -- In Vivo's Biggest Threat — Comparison To Old Models

FOCUS ON TRANSLATIONAL RESEARCH

In Vivo's Biggest Threat — Comparison To Old Models

In vivo CAR-T is not simply ex vivo without a manufacturing step. It is a different modality that relies on biological systems to regulate outcomes.

Best Practices For Quantitative Western Blot Analysis With Replicate Samples

Learn how to design, normalize, and interpret replicate western blot experiments to ensure reproducible protein quantification with fold change calculations, CV analysis, and visualization strategies.

Predict The Path With Model-Driven Genetic Design Across Modalities

Traditional biomanufacturing relies heavily on trial and error. By integrating AI and mechanistic models into early design, developers can overcome productivity limits and accelerate timelines for complex modalities.

Enhancing Throughput And Reproducibility In Proteomic Analysis

Streamline proteomic workflows with consistent sample preparation. Discover how simplifying LC-MS processes can eliminate bottlenecks, improve reproducibility, and accelerate drug discovery research.

A Strategic Overview Of Fc Engineering: The Immune Code Of Antibodies

Explore how Fc engineering transforms antibodies into precise therapeutic tools by modulating immune effector functions and extending half-life to improve patient outcomes and overcome complex clinical challenges.

TRANSLATIONAL RESEARCH SOLUTIONS

Applications For Advancing Research - LICORbio

AAV Production Companion Product Solutions - Thermo Fisher Scientific

Connect With Cell & Gene: